Clinical trial
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With…
NCT00082706 · M.D. Anderson Cancer Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00082706 |
|---|---|
| Title | Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant |
| Official title | Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Urethral Cancer, Urachal Cancer |
| Intervention type | Drug |
| Interventions | 5-Fluorouracil (5-FU), Leucovorin, Cisplatin, Gemcitabine |
| Enrollment | 46 |
| Start date | Apr 23, 2003 |
| Primary completion | Dec 31, 2025 |
| Completion | Dec 31, 2025 |
| First posted | May 19, 2004 |
| Last update posted | Sep 9, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: